Q1 Productions Announces Launch of the Regulation Station, Set for March 2014
Helping Regulatory Affairs Executives around the World Remain Current on Evolving Regulatory Guidance within the Device & Diagnostic Industries, from Securing Regulatory Approval to Meeting Post-Market Vigilance Requirements
Chicago, IL, March 23, 2014 --(PR.com)-- Q1 Productions, a leading organizer of research-based, educational program content, announced today the formal launch of the Regulation Station, a unique web-based platform that provides regulatory affairs executives around the world with most up-to-date regulatory insights specific to the medical device and diagnostic industries.
The Regulation Station will provide comprehensive information by bringing together perspectives and insights from leading regulatory affairs professionals and innovative device and diagnostic manufacturers on critical challenges inherent to positive regulatory clearance and approval decisions in the US and internationally. As these industries face tremendous regulatory changes and a cycle of continuous evolution, in-line with increasingly sophisticated and complex product offerings, the need to remain current on regulatory requirements has never been more important. Weekly webinar courses provide industry professionals with an opportunity to review new guidance documents with peers, exploring the impact of new regulatory frameworks and allowing for collaboration throughout the industry.
Throughout the 45 to 60 minute presentations, webinar participants will have an opportunity to gain practical insight from their peers and leading regulatory professionals on success stories and lessons learned. With a clear focus on medical device and diagnostic regulatory affairs, Regulation Station will feature a variety of presentations including regional case studies highlighting regulations in evolving and expanding markets, as well as insightful legal perspectives providing highly targeted and relevant regulatory guidance.
Leading regulatory groups, policy leaders and executives will participate in the programs with representatives from global device and diagnostic manufacturers, legal firms, the FDA, notified bodies and industry experts.
For more information regarding the Regulation Station, visit the Q1 website at http://www.regulation-station.com/.
Contact:
Brooke Akins
Manager, Market Intelligence
Regulation Station, a division of Q1 Productions
312.602.9683
webinars@regulation-station.com
About Q1 Productions:
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences, including the life science industries. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues for the life science industry, our programs provide solutions to the urgent educational and information needs of our attendees.
The Regulation Station will provide comprehensive information by bringing together perspectives and insights from leading regulatory affairs professionals and innovative device and diagnostic manufacturers on critical challenges inherent to positive regulatory clearance and approval decisions in the US and internationally. As these industries face tremendous regulatory changes and a cycle of continuous evolution, in-line with increasingly sophisticated and complex product offerings, the need to remain current on regulatory requirements has never been more important. Weekly webinar courses provide industry professionals with an opportunity to review new guidance documents with peers, exploring the impact of new regulatory frameworks and allowing for collaboration throughout the industry.
Throughout the 45 to 60 minute presentations, webinar participants will have an opportunity to gain practical insight from their peers and leading regulatory professionals on success stories and lessons learned. With a clear focus on medical device and diagnostic regulatory affairs, Regulation Station will feature a variety of presentations including regional case studies highlighting regulations in evolving and expanding markets, as well as insightful legal perspectives providing highly targeted and relevant regulatory guidance.
Leading regulatory groups, policy leaders and executives will participate in the programs with representatives from global device and diagnostic manufacturers, legal firms, the FDA, notified bodies and industry experts.
For more information regarding the Regulation Station, visit the Q1 website at http://www.regulation-station.com/.
Contact:
Brooke Akins
Manager, Market Intelligence
Regulation Station, a division of Q1 Productions
312.602.9683
webinars@regulation-station.com
About Q1 Productions:
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences, including the life science industries. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues for the life science industry, our programs provide solutions to the urgent educational and information needs of our attendees.
Contact
Q1 Productions
Erica Abdnour
(312) 955-0729
http://www.q1productions.com
Fax: (312) 873-3969
Erica Abdnour
(312) 955-0729
http://www.q1productions.com
Fax: (312) 873-3969
Contact
Categories